GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Spectral Medical Inc (OTCPK:EDTXF) » Definitions » EV-to-EBITDA

Spectral Medical (Spectral Medical) EV-to-EBITDA : -8.84 (As of May. 06, 2024)


View and export this data going back to . Start your Free Trial

What is Spectral Medical EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Spectral Medical's enterprise value is $91.75 Mil. Spectral Medical's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $-10.38 Mil. Therefore, Spectral Medical's EV-to-EBITDA for today is -8.84.

The historical rank and industry rank for Spectral Medical's EV-to-EBITDA or its related term are showing as below:

EDTXF' s EV-to-EBITDA Range Over the Past 10 Years
Min: -63.34   Med: -14.24   Max: -1.95
Current: -8.99

During the past 13 years, the highest EV-to-EBITDA of Spectral Medical was -1.95. The lowest was -63.34. And the median was -14.24.

EDTXF's EV-to-EBITDA is ranked worse than
100% of 116 companies
in the Medical Diagnostics & Research industry
Industry Median: 16.29 vs EDTXF: -8.99

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-06), Spectral Medical's stock price is $0.34004. Spectral Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.044. Therefore, Spectral Medical's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Spectral Medical EV-to-EBITDA Historical Data

The historical data trend for Spectral Medical's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Spectral Medical EV-to-EBITDA Chart

Spectral Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -35.62 -10.36 -7.94 -13.75 -8.89

Spectral Medical Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -13.75 -13.64 -11.81 -10.91 -8.89

Competitive Comparison of Spectral Medical's EV-to-EBITDA

For the Diagnostics & Research subindustry, Spectral Medical's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Spectral Medical's EV-to-EBITDA Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Spectral Medical's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Spectral Medical's EV-to-EBITDA falls into.



Spectral Medical EV-to-EBITDA Calculation

Spectral Medical's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=91.748/-10.383
=-8.84

Spectral Medical's current Enterprise Value is $91.75 Mil.
Spectral Medical's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-10.38 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Spectral Medical  (OTCPK:EDTXF) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Spectral Medical's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.34004/-0.044
=At Loss

Spectral Medical's share price for today is $0.34004.
Spectral Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.044.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Spectral Medical EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Spectral Medical's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Spectral Medical (Spectral Medical) Business Description

Traded in Other Exchanges
Address
135 - 2 The West Mall, Finance, Toronto, ON, CAN, M9C 1C2
Spectral Medical Inc is focused on the development and commercialization of a treatment for septic shock utilizing its endotoxin activity assay (EAA) diagnostic and the toraymyxin therapeutic. The company also manufactures and sells proprietary reagents. The product line of the company consists of proprietary biochemical, EAA, and instrumentation. The company has one reporting segment Spectral Medical Inc. The Dialco Medical Inc. operations were considered discontinued by the company.